The research aims of the group are to develop novel Inorganic/Organic Nanocomposite Particles (I/O-NP) for use in both diagnostic and therapeutic nanomedicine. The platform technology is highly adaptable allowing for a range of applications, each with significant avenues to innovative material design and future healthcare developments. The aim is to offer new direction for nanomedicine research, providing the foundation for new research fields to emerge.

Current research programmes are aimed at developing the I/O-NP platform across several emerging healthcare applications, including Proton Beam Therapy (PBT), Magnetic Particle Imaging (MPI) and Magnetic Resonance Imaging (MRI).